Eli Lilly Diabetes Drugs - Search News

News

Eli Lilly, weight loss and type 2 diabetes

UPI News on MSN · 28m

Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.

CBS News on MSN · 5h

GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for diabetes and weight loss.

The New York Times · 4h

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

Axios on MSN1h

GLP-1 pill: Eli Lilly says its oral orforglipron showing "promising results"

A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom. Why it matters: Eli Lilly said on ...

Fierce Biotech14h

Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

8hon MSN

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results